2026. RECIPIENT-TO-DONOR ANTI-CMV IGG RATIO AS A PREDICTOR OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE-CONTROL STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Oct. 2026), e2026078. DOI:https://doi.org/10.4084/MJHID.2026.078.